Published in Cell on October 01, 1983
La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J Virol (1993) 5.89
Transcription and replication of rhabdoviruses. Microbiol Rev (1987) 4.05
In vitro assembly of U1 snRNPs. EMBO J (1987) 3.18
Quantitative determination that one of two potential RNA-binding domains of the A protein component of the U1 small nuclear ribonucleoprotein complex binds with high affinity to stem-loop II of U1 RNA. Proc Natl Acad Sci U S A (1990) 2.76
Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog (2010) 2.62
Recognition of U1 and U2 small nuclear RNAs can be altered by a 5-amino-acid segment in the U2 small nuclear ribonucleoprotein particle (snRNP) B" protein and through interactions with U2 snRNP-A' protein. Mol Cell Biol (1991) 2.33
Isolation and analysis of cDNA clones expressing human lupus La antigen. Proc Natl Acad Sci U S A (1985) 2.07
Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. J Virol (1988) 2.00
PA subunit from influenza virus polymerase complex interacts with a cellular protein with homology to a family of transcriptional activators. J Virol (2001) 1.98
Specific interaction between coronavirus leader RNA and nucleocapsid protein. J Virol (1988) 1.92
EAP, a highly conserved cellular protein associated with Epstein-Barr virus small RNAs (EBERs). EMBO J (1991) 1.90
Nucleotide sequence and host La protein interactions of rabies virus leader RNA. J Virol (1984) 1.75
Association of the lupus antigen La with a subset of U6 snRNA molecules. Nucleic Acids Res (1985) 1.72
Mosquito homolog of the La autoantigen binds to Sindbis virus RNA. J Virol (1996) 1.71
Direct interactions between autoantigen La and human immunodeficiency virus leader RNA. J Virol (1994) 1.70
A specific 31-nucleotide domain of U1 RNA directly interacts with the 70K small nuclear ribonucleoprotein component. Mol Cell Biol (1989) 1.68
Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin Immunol (2011) 1.67
5' processing of tRNA precursors can Be modulated by the human La antigen phosphoprotein. Mol Cell Biol (1998) 1.49
Recognition of nascent RNA by the human La antigen: conserved and divergent features of structure and function. Mol Cell Biol (2001) 1.43
Leucine periodicity of U2 small nuclear ribonucleoprotein particle (snRNP) A' protein is implicated in snRNP assembly via protein-protein interactions. Mol Cell Biol (1991) 1.37
Intracellular redistribution of truncated La protein produced by poliovirus 3Cpro-mediated cleavage. J Virol (1999) 1.33
La autoantigen enhances translation of BiP mRNA. Nucleic Acids Res (2001) 1.33
In vitro assembly of a functional nucleocapsid from the negative-stranded genome RNA of a defective interfering particle of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1988) 1.31
Rapid inhibition of processing and assembly of small nuclear ribonucleoproteins after infection with vesicular stomatitis virus. Mol Cell Biol (1987) 1.29
Influenza A virus expresses high levels of an unusual class of small viral leader RNAs in infected cells. MBio (2010) 1.27
Initiation of vesicular stomatitis virus mutant polR1 transcription internally at the N gene in vitro. J Virol (1997) 1.27
Autoantigenicity of Ro/SSA antigen is related to a nucleocapsid protein of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1991) 1.26
Interplay between innate immunity and negative-strand RNA viruses: towards a rational model. Microbiol Mol Biol Rev (2011) 1.22
Characterization and purification of lupus antigen La, and RNA-binding protein. Mol Cell Biol (1985) 1.10
Fine epitope mapping of the human SS-B/La protein. Identification of a distinct autoepitope homologous to a viral gag polyprotein. J Clin Invest (1990) 1.08
The human La (SS-B) autoantigen interacts with DDX15/hPrp43, a putative DEAH-box RNA helicase. RNA (2002) 1.07
The La antigen inhibits the activation of the interferon-inducible protein kinase PKR by sequestering and unwinding double-stranded RNA. Nucleic Acids Res (1994) 1.01
Cellular La protein shields nonsegmented negative-strand RNA viral leader RNA from RIG-I and enhances virus growth by diverse mechanisms. J Virol (2008) 0.98
Inhibition of DNA-dependent transcription by the leader RNA of vesicular stomatitis virus: role of specific nucleotide sequences and cell protein binding. Mol Cell Biol (1985) 0.97
A seroepidemiological study of cytomegalovirus and Epstein-Barr virus in rheumatoid arthritis and sicca syndrome. Ann Rheum Dis (1985) 0.96
The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivo. RNA (2001) 0.94
Temporal correlation of antibody responses to different epitopes of the human La autoantigen. J Clin Invest (1990) 0.90
Genome RNA terminus conservation and diversity among vesiculoviruses. J Virol (1987) 0.87
Sonchus yellow net rhabdovirus nuclear viroplasms contain polymerase-associated proteins. J Virol (1998) 0.87
Detection and sequence of plus-strand leader RNA of sonchus yellow net virus, a plant rhabdovirus. Proc Natl Acad Sci U S A (1986) 0.87
Molecular analysis of the RNA and protein components recognized by anti-La(SS-B) autoantibodies. Clin Exp Immunol (1985) 0.87
Vesicular stomatitis virus in Drosophila melanogaster cells: lack of leader RNA transport into the nuclei and frequent abortion of the replication step. J Virol (1987) 0.86
Specific phosphorylated forms of glyceraldehyde 3-phosphate dehydrogenase associate with human parainfluenza virus type 3 and inhibit viral transcription in vitro. J Virol (2000) 0.85
Specific interaction of heterogeneous nuclear ribonucleoprotein particle U with the leader RNA sequence of vesicular stomatitis virus. J Virol (1998) 0.84
Viral transcription is necessary and sufficient for vesicular stomatitis virus to inhibit maturation of small nuclear ribonucleoproteins. J Virol (1989) 0.81
The La and related RNA-binding proteins (LARPs): structures, functions, and evolving perspectives. Wiley Interdiscip Rev RNA (2017) 0.76
Inhibition of adenovirus DNA replication by vesicular stomatitis virus leader RNA. J Virol (1988) 0.75
RNA recognition: towards identifying determinants of specificity. Trends Biochem Sci (1991) 9.03
Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell (2001) 8.04
A common RNA recognition motif identified within a defined U1 RNA binding domain of the 70K U1 snRNP protein. Cell (1989) 7.42
La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J Virol (1993) 5.89
Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc Natl Acad Sci U S A (2000) 4.99
Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs. Mol Cell Biol (1993) 4.63
Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature (1995) 4.53
Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J Virol (1990) 4.24
Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med (1992) 4.11
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med (1992) 3.75
The origins of defective interfering particles of the negative-strand RNA viruses. Cell (1981) 3.50
ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev (1999) 3.45
Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes. Mol Cell Biol (1997) 3.21
Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am J Hum Genet (1997) 3.05
Selection of a subset of mRNAs from combinatorial 3' untranslated region libraries using neuronal RNA-binding protein Hel-N1. Proc Natl Acad Sci U S A (1994) 2.95
RNA-binding domain of the A protein component of the U1 small nuclear ribonucleoprotein analyzed by NMR spectroscopy is structurally similar to ribosomal proteins. Proc Natl Acad Sci U S A (1991) 2.87
ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J Cell Sci (1998) 2.83
Nucleotide sequence homology at the 3' termini of RNA from vesicular stomatitis virus and its defective interfering particles. Proc Natl Acad Sci U S A (1978) 2.82
Site on the vesicular stomatitis virus genome specifying polyadenylation and the end of the L gene mRNA. J Virol (1980) 2.81
Quantitative determination that one of two potential RNA-binding domains of the A protein component of the U1 small nuclear ribonucleoprotein complex binds with high affinity to stem-loop II of U1 RNA. Proc Natl Acad Sci U S A (1990) 2.76
Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J Exp Med (1997) 2.76
ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells. Genes Dev (1999) 2.65
A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell (1987) 2.58
U1-snRNP-A protein selects a ten nucleotide consensus sequence from a degenerate RNA pool presented in various structural contexts. Nucleic Acids Res (1991) 2.49
Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J Exp Med (2000) 2.48
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J Exp Med (1994) 2.47
Genomic structure and amino acid sequence domains of the human La autoantigen. J Biol Chem (1988) 2.37
Recognition of U1 and U2 small nuclear RNAs can be altered by a 5-amino-acid segment in the U2 small nuclear ribonucleoprotein particle (snRNP) B" protein and through interactions with U2 snRNP-A' protein. Mol Cell Biol (1991) 2.33
Hel-N1/Hel-N2 proteins are bound to poly(A)+ mRNA in granular RNP structures and are implicated in neuronal differentiation. J Cell Sci (1996) 2.18
Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity (1997) 2.18
Polycistronic vesicular stomatitis virus RNA transcripts. Proc Natl Acad Sci U S A (1980) 2.16
Molecular analysis of the 60-kDa human Ro ribonucleoprotein. Proc Natl Acad Sci U S A (1988) 2.11
Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3' UTR of mRNA encoding the Id transcriptional repressor. J Neurosci (1994) 2.09
Isolation and analysis of cDNA clones expressing human lupus La antigen. Proc Natl Acad Sci U S A (1985) 2.07
The complete sequence of a unique RNA species synthesized by a DI particle of VSV. Cell (1978) 2.04
Sequence-specific contacts between the RNA polymerase of vesicular stomatitis virus and the leader RNA gene. Proc Natl Acad Sci U S A (1981) 1.95
Messenger ribonucleoprotein complexes containing human ELAV proteins: interactions with cytoskeleton and translational apparatus. J Cell Sci (1998) 1.94
Eukaryotic transcription termination factor La mediates transcript release and facilitates reinitiation by RNA polymerase III. Mol Cell Biol (1994) 1.94
Terminal sequences of vesicular stomatitis virus RNA are both complementary and conserved. J Virol (1979) 1.87
The U1 RNA-binding site of the U1 small nuclear ribonucleoprotein (snRNP)-associated A protein suggests a similarity with U2 snRNPs. Mol Cell Biol (1989) 1.87
Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J Virol (1993) 1.77
Intervening sequence between the leader region and the nucleopcapsid gene of vesicular stomatitis virus RNA. J Virol (1980) 1.76
Nucleotide sequence and host La protein interactions of rabies virus leader RNA. J Virol (1984) 1.75
Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. Proc Natl Acad Sci U S A (1990) 1.74
A specific internal RNA polymerase recognition site of VSV RNA is involved in the generation of DI particles. Cell (1979) 1.72
Direct interactions between autoantigen La and human immunodeficiency virus leader RNA. J Virol (1994) 1.70
A specific 31-nucleotide domain of U1 RNA directly interacts with the 70K small nuclear ribonucleoprotein component. Mol Cell Biol (1989) 1.68
The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J Virol (1992) 1.61
Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation. J Biol Chem (2000) 1.54
Vesicular stomatitis virus defective interfering particle containing a muted internal leader RNA gene. Proc Natl Acad Sci U S A (1981) 1.53
In vitro synthesis of messenger RNA by a defective interfering particle of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1977) 1.51
Association between the 7 S RNA and the lupus La protein varies among cell types. J Biol Chem (1983) 1.51
A host protein (La) binds to a unique species of minus-sense leader RNA during replication of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1983) 1.50
In vitro selection of an RNA epitope immunologically cross-reactive with a peptide. Proc Natl Acad Sci U S A (1992) 1.50
Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype. Oncogene (2008) 1.41
Sites of copy choice replication involved in generation of vesicular stomatitis virus defective-interfering particle RNAs. J Virol (1984) 1.40
Search for organising principles: understanding in systems biology. Syst Biol (Stevenage) (2004) 1.40
Characterization of the 3' terminus of RNA isolated from vesicular stomatitis virus and from its defective interfering particles. Proc Natl Acad Sci U S A (1977) 1.40
Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J Exp Med (1993) 1.38
Leucine periodicity of U2 small nuclear ribonucleoprotein particle (snRNP) A' protein is implicated in snRNP assembly via protein-protein interactions. Mol Cell Biol (1991) 1.37
Rapid and transient localization of the leader RNA of vesicular stomatitis virus in the nuclei of infected cells. Proc Natl Acad Sci U S A (1982) 1.35
RNA polymerase-associated interactions near template promoter sequences of defective interfering particles of vesicular stomatitis virus. J Virol (1982) 1.34
Exploring molecular diversity with combinatorial shape libraries. Trends Biochem Sci (1994) 1.33
Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells. Immunology (1991) 1.30
Rapid inhibition of processing and assembly of small nuclear ribonucleoproteins after infection with vesicular stomatitis virus. Mol Cell Biol (1987) 1.29
Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. Proc Natl Acad Sci U S A (1992) 1.28
A sequence-specific conformational epitope on U1 RNA is recognized by a unique autoantibody. Proc Natl Acad Sci U S A (1988) 1.26
Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening. J Biol Chem (2000) 1.26
Nature of the 3'-terminal sequences of the plus and minus strands of the S1 gene of reovirus serotypes 1, 2 and 3. Virology (1980) 1.22
Overexpression of the arginine-rich carboxy-terminal region of U1 snRNP 70K inhibits both splicing and nucleocytoplasmic transport of mRNA. Genes Dev (1995) 1.21
Specificity and idiotypic analysis of a monoclonal anti-Sm antibody with anti-DNA activity. J Immunol (1985) 1.20
Autoantibodies specific for U1 RNA and initiator methionine tRNA. J Biol Chem (1986) 1.15
High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections. J Infect Dis (2000) 1.14
In vitro selection of aptamers from RNA libraries. Methods Mol Biol (1999) 1.12
Base mutations in the terminal noncoding regions of the genome of vesicular stomatitis virus isolated from persistent infections of L cells. Virology (1985) 1.11
Molecular composition of Ro small ribonucleoprotein complexes in human cells. Intracellular localization of the 60- and 52-kD proteins. J Clin Invest (1994) 1.11
The plus strand of reovirus gene S2 is identical with its in vitro transcript. Virology (1980) 1.09
The U1 small nuclear ribonucleoprotein (snRNP) 70K protein is transported independently of U1 snRNP particles via a nuclear localization signal in the RNA-binding domain. Mol Cell Biol (1994) 1.09
Sequential synthesis of small capped RNA transcripts in vitro by vesicular stomatitis virus. Virology (1983) 1.08
Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites. Nucleic Acids Res (1991) 1.07
RNA binding specificity of a Drosophila snRNP protein that shares sequence homology with mammalian U1-A and U2-B" proteins. Nucleic Acids Res (1992) 1.07
Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells. Int J Cancer (1996) 1.02
Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing. Int Immunol (1997) 1.00
Analysis of autoantibody binding to different regions of the human La antigen expressed in recombinant fusion proteins. J Immunol (1988) 1.00
Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1. J Virol (2000) 0.98
Presentation of epstein-barr virus latency antigens to CD8(+), interferon-gamma-secreting, T lymphocytes. Eur J Immunol (1999) 0.97
Antigenicity of a recombinant Ro (SS-A) fusion protein. Arthritis Rheum (1990) 0.96
Cytotoxic CD8+ T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts: immunodominance is elicited by a peptide epitope that is presented at low levels in vitro. J Immunol (1997) 0.95
RNA sequence and transcriptional properties of the 3' end of the Newcastle disease virus genome. Virology (1985) 0.95
Anti-La antibody production by MRL-1pr/1pr mice. Analysis of fine specificity. J Immunol (1991) 0.94